Rank | Gene Set | Z-score |
---|---|---|
1 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.21082885 |
2 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.21082885 |
3 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.21082885 |
4 | modulation by symbiont of host immune response (GO:0052553) | 6.21082885 |
5 | positive regulation by symbiont of host defense response (GO:0052509) | 6.21082885 |
6 | modulation by symbiont of host defense response (GO:0052031) | 6.21082885 |
7 | sulfation (GO:0051923) | 5.14956402 |
8 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.97181927 |
9 | neutrophil activation involved in immune response (GO:0002283) | 4.74536129 |
10 | response to peptidoglycan (GO:0032494) | 4.55081782 |
11 | flavonoid metabolic process (GO:0009812) | 4.51579985 |
12 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 4.40187413 |
13 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.33729014 |
14 | cellular extravasation (GO:0045123) | 4.31204829 |
15 | response to host immune response (GO:0052572) | 4.30251656 |
16 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.30251656 |
17 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.23302406 |
18 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 4.22642166 |
19 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 4.22642166 |
20 | positive regulation of fatty acid oxidation (GO:0046321) | 4.08243096 |
21 | negative regulation of mast cell activation (GO:0033004) | 4.07543018 |
22 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 4.05818337 |
23 | immunoglobulin mediated immune response (GO:0016064) | 4.05176021 |
24 | regulation of mast cell degranulation (GO:0043304) | 4.03952325 |
25 | macrophage activation involved in immune response (GO:0002281) | 3.99534506 |
26 | cellular response to ATP (GO:0071318) | 3.98903187 |
27 | regulation of mononuclear cell migration (GO:0071675) | 3.97888166 |
28 | respiratory burst (GO:0045730) | 3.92141369 |
29 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.86681266 |
30 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.85190351 |
31 | response to host (GO:0075136) | 3.85190351 |
32 | response to host defenses (GO:0052200) | 3.85190351 |
33 | positive regulation of antigen processing and presentation (GO:0002579) | 3.84803965 |
34 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.81501654 |
35 | microglial cell activation (GO:0001774) | 3.80083432 |
36 | regulation of cholesterol storage (GO:0010885) | 3.68140579 |
37 | indole-containing compound catabolic process (GO:0042436) | 3.64785117 |
38 | indolalkylamine catabolic process (GO:0046218) | 3.64785117 |
39 | tryptophan catabolic process (GO:0006569) | 3.64785117 |
40 | transepithelial transport (GO:0070633) | 3.64085319 |
41 | angiotensin maturation (GO:0002003) | 3.61570994 |
42 | superoxide anion generation (GO:0042554) | 3.59515148 |
43 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.58666101 |
44 | positive regulation of mast cell degranulation (GO:0043306) | 3.58666101 |
45 | regulation of antigen processing and presentation (GO:0002577) | 3.56315951 |
46 | regulation of triglyceride catabolic process (GO:0010896) | 3.55288910 |
47 | behavioral response to nicotine (GO:0035095) | 3.52677515 |
48 | regulation of mast cell activation (GO:0033003) | 3.51163037 |
49 | neutrophil activation (GO:0042119) | 3.50570433 |
50 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.49431119 |
51 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.49090040 |
52 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 3.48598653 |
53 | positive regulation of mast cell activation (GO:0033005) | 3.47772001 |
54 | detection of molecule of bacterial origin (GO:0032490) | 3.45719701 |
55 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.44311288 |
56 | cell proliferation in forebrain (GO:0021846) | 3.44019525 |
57 | regulation of cell proliferation involved in kidney development (GO:1901722) | 3.43449547 |
58 | regulation of monocyte chemotaxis (GO:0090025) | 3.43356486 |
59 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.41758771 |
60 | sulfate transmembrane transport (GO:1902358) | 3.41666399 |
61 | positive regulation of interferon-alpha production (GO:0032727) | 3.41321546 |
62 | negative regulation of interleukin-12 production (GO:0032695) | 3.39771948 |
63 | positive regulation of type 2 immune response (GO:0002830) | 3.35622304 |
64 | granulocyte activation (GO:0036230) | 3.32501324 |
65 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.31094233 |
66 | intestinal absorption (GO:0050892) | 3.29189531 |
67 | regulation of interferon-alpha production (GO:0032647) | 3.28860272 |
68 | cellular anion homeostasis (GO:0030002) | 3.25264134 |
69 | macrophage activation (GO:0042116) | 3.24485120 |
70 | lipoxygenase pathway (GO:0019372) | 3.22798505 |
71 | germinal center formation (GO:0002467) | 3.22425978 |
72 | response to muramyl dipeptide (GO:0032495) | 3.20595974 |
73 | leukocyte aggregation (GO:0070486) | 3.19414380 |
74 | positive regulation of cAMP-mediated signaling (GO:0043950) | 3.18400093 |
75 | regulation of RIG-I signaling pathway (GO:0039535) | 3.17921807 |
76 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.17839873 |
77 | detection of other organism (GO:0098543) | 3.16346511 |
78 | negative regulation of systemic arterial blood pressure (GO:0003085) | 3.13884549 |
79 | kynurenine metabolic process (GO:0070189) | 3.11081087 |
80 | dendritic cell chemotaxis (GO:0002407) | 3.07929842 |
81 | indolalkylamine metabolic process (GO:0006586) | 3.05189286 |
82 | tryptophan metabolic process (GO:0006568) | 3.04504309 |
83 | negative regulation of granulocyte differentiation (GO:0030853) | 3.04398059 |
84 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.02219200 |
85 | dendritic cell migration (GO:0036336) | 2.99047905 |
86 | regulation of leukocyte degranulation (GO:0043300) | 2.98269712 |
87 | eosinophil chemotaxis (GO:0048245) | 2.97061738 |
88 | regulation of activation of Janus kinase activity (GO:0010533) | 2.96032195 |
89 | regulation of fever generation (GO:0031620) | 2.92393737 |
90 | positive regulation of fatty acid transport (GO:2000193) | 2.91254920 |
91 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.90464140 |
92 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.90196737 |
93 | positive regulation of heat generation (GO:0031652) | 2.89712516 |
94 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.87543294 |
95 | regulation of glomerulus development (GO:0090192) | 2.87509440 |
96 | regulation of integrin activation (GO:0033623) | 2.85784767 |
97 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.84864502 |
98 | NIK/NF-kappaB signaling (GO:0038061) | 2.83312582 |
99 | positive regulation of interleukin-17 production (GO:0032740) | 2.81102318 |
100 | cellular response to exogenous dsRNA (GO:0071360) | 2.80996941 |
101 | L-fucose catabolic process (GO:0042355) | 2.80942877 |
102 | fucose catabolic process (GO:0019317) | 2.80942877 |
103 | L-fucose metabolic process (GO:0042354) | 2.80942877 |
104 | interferon-gamma secretion (GO:0072643) | 2.79644232 |
105 | regulation of platelet aggregation (GO:0090330) | 2.79182637 |
106 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.78710220 |
107 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.77995574 |
108 | cellular biogenic amine catabolic process (GO:0042402) | 2.76990428 |
109 | amine catabolic process (GO:0009310) | 2.76990428 |
110 | vitamin biosynthetic process (GO:0009110) | 2.75111929 |
111 | myeloid cell activation involved in immune response (GO:0002275) | 2.75108170 |
112 | B cell mediated immunity (GO:0019724) | 2.74772360 |
113 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.74258993 |
114 | positive regulation of icosanoid secretion (GO:0032305) | 2.73801415 |
115 | detection of external biotic stimulus (GO:0098581) | 2.72591746 |
116 | negative regulation of leukocyte migration (GO:0002686) | 2.71595919 |
117 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.71342521 |
118 | positive regulation of interleukin-12 production (GO:0032735) | 2.71132838 |
119 | negative regulation of fibrinolysis (GO:0051918) | 2.70237685 |
120 | positive regulation of systemic arterial blood pressure (GO:0003084) | 2.69721835 |
121 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.69417392 |
122 | sulfate transport (GO:0008272) | 2.68883149 |
123 | positive regulation of chemokine production (GO:0032722) | 2.67993319 |
124 | regulation of lymphocyte chemotaxis (GO:1901623) | 2.67884197 |
125 | regulation of guanylate cyclase activity (GO:0031282) | 2.66989889 |
126 | lipoprotein transport (GO:0042953) | 2.66008804 |
127 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.65824690 |
128 | regulation of macrophage cytokine production (GO:0010935) | 2.65666142 |
129 | lung morphogenesis (GO:0060425) | 2.65665050 |
130 | monocyte chemotaxis (GO:0002548) | 2.65502735 |
131 | neutrophil mediated immunity (GO:0002446) | 2.64820708 |
132 | myeloid dendritic cell activation (GO:0001773) | 2.63979940 |
133 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.63630122 |
134 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.63575400 |
135 | negative regulation of lipid storage (GO:0010888) | 2.63113167 |
136 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.62680564 |
137 | positive regulation of lymphocyte migration (GO:2000403) | 2.61831633 |
138 | tolerance induction (GO:0002507) | 2.61049209 |
139 | positive regulation of digestive system process (GO:0060456) | 2.61016839 |
140 | eosinophil migration (GO:0072677) | 2.60801477 |
141 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.60539325 |
142 | positive regulation of lipid catabolic process (GO:0050996) | 2.59538996 |
143 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.59043588 |
144 | myeloid dendritic cell differentiation (GO:0043011) | 2.59006245 |
145 | detection of bacterium (GO:0016045) | 2.58734868 |
146 | regulation of germinal center formation (GO:0002634) | 2.58549083 |
147 | DNA deamination (GO:0045006) | 2.56769166 |
148 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.56636954 |
149 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.54458585 |
150 | regulation of lymphocyte migration (GO:2000401) | 2.54189731 |
151 | neutrophil chemotaxis (GO:0030593) | 2.54109637 |
152 | response to protozoan (GO:0001562) | 2.53819949 |
153 | defense response to protozoan (GO:0042832) | 2.53769661 |
154 | negative regulation of protein tyrosine kinase activity (GO:0061099) | 2.53758531 |
155 | positive regulation of interferon-beta production (GO:0032728) | 2.53712502 |
156 | regulation of interleukin-12 production (GO:0032655) | 2.53217185 |
157 | diacylglycerol metabolic process (GO:0046339) | 2.52601521 |
158 | positive regulation of prostaglandin secretion (GO:0032308) | 2.52416218 |
159 | low-density lipoprotein particle remodeling (GO:0034374) | 2.49510095 |
160 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.49112520 |
161 | NAD biosynthetic process (GO:0009435) | 2.49009405 |
162 | cytidine metabolic process (GO:0046087) | 2.47609331 |
163 | cytidine catabolic process (GO:0006216) | 2.47609331 |
164 | cytidine deamination (GO:0009972) | 2.47609331 |
165 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.38553091 |
166 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.38202220 |
167 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.36153614 |
168 | positive regulation of defense response to virus by host (GO:0002230) | 2.35943422 |
169 | negative regulation of platelet activation (GO:0010544) | 2.35584356 |
170 | regulation of cholesterol homeostasis (GO:2000188) | 2.34541643 |
171 | regulation of digestive system process (GO:0044058) | 2.34017992 |
172 | cellular response to pH (GO:0071467) | 2.32541242 |
173 | regulation of prostaglandin secretion (GO:0032306) | 2.32492517 |
174 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.30913928 |
175 | plasma lipoprotein particle assembly (GO:0034377) | 2.30001725 |
176 | regulation of phospholipid biosynthetic process (GO:0071071) | 2.29710195 |
177 | regulation of cellular extravasation (GO:0002691) | 2.29562405 |
178 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.29085684 |
179 | regulation of icosanoid secretion (GO:0032303) | 2.28219617 |
180 | indole-containing compound metabolic process (GO:0042430) | 2.25828400 |
181 | regulation of sequestering of triglyceride (GO:0010889) | 2.25467262 |
182 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.24271076 |
183 | regulation of vitamin metabolic process (GO:0030656) | 2.24104589 |
184 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.24083388 |
185 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.23744162 |
186 | aromatic amino acid family catabolic process (GO:0009074) | 2.23187499 |
187 | auditory receptor cell differentiation (GO:0042491) | 2.22594222 |
188 | regulation of regulatory T cell differentiation (GO:0045589) | 2.22486650 |
189 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.22196947 |
190 | estrogen metabolic process (GO:0008210) | 2.21184061 |
191 | kidney morphogenesis (GO:0060993) | 2.20849122 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.14228873 |
2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.48354821 |
3 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 4.74236482 |
4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.79114882 |
5 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.44685207 |
6 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.27122535 |
7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.23883624 |
8 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.13076164 |
9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.08378629 |
10 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.98220190 |
11 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.81043697 |
12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.52673510 |
13 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.46400813 |
14 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.45571385 |
15 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.40203218 |
16 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.39823758 |
17 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.36495306 |
18 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.30536354 |
19 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.27385296 |
20 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.22465734 |
21 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.13773215 |
22 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.03631227 |
23 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.98500017 |
24 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.97360327 |
25 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.91039668 |
26 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.89166602 |
27 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.79531372 |
28 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.74571256 |
29 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.71661806 |
30 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.64092358 |
31 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.63363568 |
32 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.62646995 |
33 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.62407106 |
34 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.61907508 |
35 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.61265245 |
36 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.59035509 |
37 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.58277307 |
38 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.55952961 |
39 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.55184615 |
40 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.53544337 |
41 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.50008650 |
42 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.47568373 |
43 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.47331382 |
44 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.46017979 |
45 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.44142259 |
46 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.43008163 |
47 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.42828534 |
48 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.42793940 |
49 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.42701628 |
50 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.42123092 |
51 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.41227934 |
52 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.40209433 |
53 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.38849694 |
54 | * NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.38340385 |
55 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.37249217 |
56 | CJUN_26792858_Chip-Seq_BT549_Human | 1.36583800 |
57 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.36398939 |
58 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.35545547 |
59 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.35435840 |
60 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.34695268 |
61 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.34522209 |
62 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.34449184 |
63 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.33474984 |
64 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.31805050 |
65 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30420243 |
66 | * EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.30332682 |
67 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.30037774 |
68 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.29237887 |
69 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.29037834 |
70 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.24584435 |
71 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.24043124 |
72 | * SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.22269936 |
73 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.22159598 |
74 | * PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.22081092 |
75 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.21666586 |
76 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.21176121 |
77 | * PU1_27457419_Chip-Seq_LIVER_Mouse | 1.21002944 |
78 | * P300_18555785_Chip-Seq_ESCs_Mouse | 1.20493808 |
79 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.19770196 |
80 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.19359657 |
81 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.18957794 |
82 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.18931211 |
83 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.18097841 |
84 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.17908686 |
85 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.17773965 |
86 | * KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.15913272 |
87 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.15637143 |
88 | * ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.15544697 |
89 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.14456345 |
90 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13209681 |
91 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.13143663 |
92 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.13024549 |
93 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.12947694 |
94 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.11678201 |
95 | * SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.11529638 |
96 | * RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.11513782 |
97 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11360896 |
98 | * ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.10899324 |
99 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.09556402 |
100 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.08973174 |
101 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.08071182 |
102 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.07579816 |
103 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.07573160 |
104 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.07268030 |
105 | SPI1_23127762_ChIP-Seq_K562_Human | 1.07220459 |
106 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.06500491 |
107 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.06237919 |
108 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.05519965 |
109 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.04937739 |
110 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.02896422 |
111 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.02755601 |
112 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.02241981 |
113 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.02123279 |
114 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01677261 |
115 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.01584332 |
116 | * KDM2B_26808549_Chip-Seq_REH_Human | 1.01504398 |
117 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.01286876 |
118 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.00701757 |
119 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00507360 |
120 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.00089018 |
121 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.00018256 |
122 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.99656549 |
123 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.99531296 |
124 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.99278503 |
125 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.99113152 |
126 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.98341436 |
127 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.98293708 |
128 | * FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.97001030 |
129 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96290159 |
130 | * MYB_26560356_Chip-Seq_TH2_Human | 0.96265120 |
131 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.95791335 |
132 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.95342437 |
133 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.95155788 |
134 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.94790330 |
135 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.94779063 |
136 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.94174818 |
137 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94020910 |
138 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.93675114 |
139 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.91881345 |
140 | ERA_21632823_ChIP-Seq_H3396_Human | 0.91855571 |
141 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.91732580 |
142 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.91729050 |
143 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.91644761 |
144 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91409721 |
145 | P300_27268052_Chip-Seq_Bcells_Human | 0.91246675 |
146 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.90887625 |
147 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.89798767 |
148 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88832461 |
149 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.88586180 |
150 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.88494253 |
151 | P300_19829295_ChIP-Seq_ESCs_Human | 0.88344900 |
152 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.87944539 |
153 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.87895331 |
154 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.87274634 |
155 | VDR_22108803_ChIP-Seq_LS180_Human | 0.87056489 |
156 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.86779400 |
157 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.86656406 |
158 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.86145559 |
159 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.86024025 |
160 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.85589232 |
161 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.85588723 |
162 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.84949663 |
163 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.84245092 |
164 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84065090 |
165 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.83988877 |
166 | * RAC3_21632823_ChIP-Seq_H3396_Human | 0.83290176 |
167 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.83027606 |
168 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.82773121 |
169 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.80839616 |
170 | GATA3_26560356_Chip-Seq_TH2_Human | 0.80621714 |
171 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.80596412 |
172 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.80455639 |
173 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.80433302 |
174 | NCOR_22424771_ChIP-Seq_293T_Human | 0.80219415 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 5.14133043 |
2 | MP0005360_urolithiasis | 4.20411166 |
3 | MP0001835_abnormal_antigen_presentation | 4.15491792 |
4 | MP0003724_increased_susceptibility_to | 3.55883490 |
5 | MP0004510_myositis | 3.48029705 |
6 | MP0002148_abnormal_hypersensitivity_rea | 3.33057085 |
7 | MP0003303_peritoneal_inflammation | 3.17700346 |
8 | MP0003436_decreased_susceptibility_to | 3.16918222 |
9 | MP0002419_abnormal_innate_immunity | 3.14983960 |
10 | MP0001790_abnormal_immune_system | 2.91685441 |
11 | MP0005387_immune_system_phenotype | 2.91685441 |
12 | MP0005000_abnormal_immune_tolerance | 2.90309640 |
13 | MP0005451_abnormal_body_composition | 2.76002394 |
14 | MP0009785_altered_susceptibility_to | 2.68232223 |
15 | MP0006082_CNS_inflammation | 2.61344544 |
16 | MP0005025_abnormal_response_to | 2.57816709 |
17 | MP0005365_abnormal_bile_salt | 2.53921147 |
18 | MP0002452_abnormal_antigen_presenting | 2.52169287 |
19 | MP0001800_abnormal_humoral_immune | 2.43738312 |
20 | MP0003195_calcinosis | 2.38925518 |
21 | MP0005671_abnormal_response_to | 2.35466717 |
22 | MP0002723_abnormal_immune_serum | 2.28890643 |
23 | MP0001986_abnormal_taste_sensitivity | 2.19215973 |
24 | MP0001485_abnormal_pinna_reflex | 2.18191414 |
25 | MP0002405_respiratory_system_inflammati | 2.18008378 |
26 | MP0003172_abnormal_lysosome_physiology | 2.14936548 |
27 | MP0005310_abnormal_salivary_gland | 2.08849951 |
28 | MP0001819_abnormal_immune_cell | 2.07505226 |
29 | MP0002420_abnormal_adaptive_immunity | 2.05840588 |
30 | MP0002876_abnormal_thyroid_physiology | 2.05471841 |
31 | MP0005670_abnormal_white_adipose | 1.99826187 |
32 | MP0000685_abnormal_immune_system | 1.92095737 |
33 | MP0000343_altered_response_to | 1.90188636 |
34 | MP0005085_abnormal_gallbladder_physiolo | 1.87959419 |
35 | MP0001533_abnormal_skeleton_physiology | 1.86250135 |
36 | MP0009333_abnormal_splenocyte_physiolog | 1.84647043 |
37 | MP0001666_abnormal_nutrient_absorption | 1.82767661 |
38 | MP0004019_abnormal_vitamin_homeostasis | 1.79858468 |
39 | MP0009764_decreased_sensitivity_to | 1.79685444 |
40 | MP0002138_abnormal_hepatobiliary_system | 1.78713270 |
41 | MP0001853_heart_inflammation | 1.76515163 |
42 | MP0001845_abnormal_inflammatory_respons | 1.72573252 |
43 | MP0010155_abnormal_intestine_physiology | 1.72325793 |
44 | MP0010329_abnormal_lipoprotein_level | 1.71742597 |
45 | MP0008260_abnormal_autophagy | 1.67327683 |
46 | MP0008872_abnormal_physiological_respon | 1.63572527 |
47 | MP0001851_eye_inflammation | 1.60781216 |
48 | MP0008875_abnormal_xenobiotic_pharmacok | 1.59419384 |
49 | MP0003879_abnormal_hair_cell | 1.59395833 |
50 | MP0002277_abnormal_respiratory_mucosa | 1.59333117 |
51 | MP0005058_abnormal_lysosome_morphology | 1.58320204 |
52 | MP0008004_abnormal_stomach_pH | 1.56807238 |
53 | MP0005464_abnormal_platelet_physiology | 1.55529052 |
54 | MP0002933_joint_inflammation | 1.46835718 |
55 | MP0003828_pulmonary_edema | 1.44173912 |
56 | MP0003646_muscle_fatigue | 1.42026483 |
57 | MP0002132_abnormal_respiratory_system | 1.40782391 |
58 | MP0000716_abnormal_immune_system | 1.40601115 |
59 | MP0005390_skeleton_phenotype | 1.40350125 |
60 | MP0003448_altered_tumor_morphology | 1.37224818 |
61 | MP0003638_abnormal_response/metabolism_ | 1.34048746 |
62 | MP0009379_abnormal_foot_pigmentation | 1.32701122 |
63 | MP0002102_abnormal_ear_morphology | 1.31123522 |
64 | MP0004947_skin_inflammation | 1.30844331 |
65 | MP0001765_abnormal_ion_homeostasis | 1.29271032 |
66 | MP0000569_abnormal_digit_pigmentation | 1.27632290 |
67 | MP0003075_altered_response_to | 1.27418800 |
68 | MP0002998_abnormal_bone_remodeling | 1.23921956 |
69 | MP0002398_abnormal_bone_marrow | 1.22645165 |
70 | MP0005646_abnormal_pituitary_gland | 1.21851959 |
71 | MP0003300_gastrointestinal_ulcer | 1.21621073 |
72 | MP0000678_abnormal_parathyroid_gland | 1.20569639 |
73 | MP0003252_abnormal_bile_duct | 1.19686474 |
74 | MP0002736_abnormal_nociception_after | 1.13947579 |
75 | MP0002396_abnormal_hematopoietic_system | 1.13206826 |
76 | MP0000015_abnormal_ear_pigmentation | 1.12294664 |
77 | MP0000689_abnormal_spleen_morphology | 1.11833588 |
78 | MP0003690_abnormal_glial_cell | 1.11415820 |
79 | MP0002653_abnormal_ependyma_morphology | 1.10287083 |
80 | MP0004130_abnormal_muscle_cell | 1.09539404 |
81 | MP0000465_gastrointestinal_hemorrhage | 1.09043112 |
82 | MP0008469_abnormal_protein_level | 1.08624596 |
83 | MP0009765_abnormal_xenobiotic_induced | 1.07234379 |
84 | MP0004782_abnormal_surfactant_physiolog | 1.06639015 |
85 | MP0002837_dystrophic_cardiac_calcinosis | 1.06288548 |
86 | MP0002160_abnormal_reproductive_system | 1.05616653 |
87 | MP0002429_abnormal_blood_cell | 1.05423803 |
88 | MP0005389_reproductive_system_phenotype | 1.05087309 |
89 | MP0000490_abnormal_crypts_of | 1.03105117 |
90 | MP0001764_abnormal_homeostasis | 1.02820914 |
91 | MP0005166_decreased_susceptibility_to | 1.02348834 |
92 | MP0005332_abnormal_amino_acid | 1.02331665 |
93 | MP0001664_abnormal_digestion | 1.00787100 |
94 | MP0005167_abnormal_blood-brain_barrier | 0.98141606 |
95 | MP0005448_abnormal_energy_balance | 0.97305096 |
96 | MP0003950_abnormal_plasma_membrane | 0.96859798 |
97 | MP0005084_abnormal_gallbladder_morpholo | 0.96544367 |
98 | MP0003718_maternal_effect | 0.96468248 |
99 | MP0001663_abnormal_digestive_system | 0.95956477 |
100 | MP0002136_abnormal_kidney_physiology | 0.94277662 |
101 | MP0005636_abnormal_mineral_homeostasis | 0.93446916 |
102 | MP0008438_abnormal_cutaneous_collagen | 0.92779359 |
103 | MP0002722_abnormal_immune_system | 0.92463045 |
104 | MP0001542_abnormal_bone_strength | 0.91382342 |
105 | MP0009384_cardiac_valve_regurgitation | 0.90154882 |
106 | MP0003045_fibrosis | 0.89938109 |
107 | MP0004264_abnormal_extraembryonic_tissu | 0.89257208 |
108 | MP0002735_abnormal_chemical_nociception | 0.88959761 |
109 | MP0002118_abnormal_lipid_homeostasis | 0.87549365 |
110 | MP0005551_abnormal_eye_electrophysiolog | 0.87274384 |
111 | MP0000230_abnormal_systemic_arterial | 0.87166648 |
112 | MP0000858_altered_metastatic_potential | 0.86357583 |
113 | MP0004885_abnormal_endolymph | 0.85988934 |
114 | MP0009643_abnormal_urine_homeostasis | 0.84847284 |
115 | MP0000604_amyloidosis | 0.83966917 |
116 | MP0003011_delayed_dark_adaptation | 0.82404926 |
117 | MP0001873_stomach_inflammation | 0.82367286 |
118 | MP0004742_abnormal_vestibular_system | 0.80652769 |
119 | MP0002971_abnormal_brown_adipose | 0.79801696 |
120 | MP0009697_abnormal_copulation | 0.79191001 |
121 | MP0005164_abnormal_response_to | 0.79092828 |
122 | MP0000049_abnormal_middle_ear | 0.77177653 |
123 | MP0004043_abnormal_pH_regulation | 0.76919015 |
124 | MP0000609_abnormal_liver_physiology | 0.76727069 |
125 | MP0005397_hematopoietic_system_phenotyp | 0.76592888 |
126 | MP0001545_abnormal_hematopoietic_system | 0.76592888 |
127 | MP0003453_abnormal_keratinocyte_physiol | 0.76541101 |
128 | MP0001501_abnormal_sleep_pattern | 0.76530232 |
129 | MP0003806_abnormal_nucleotide_metabolis | 0.76459817 |
130 | MP0009115_abnormal_fat_cell | 0.75588680 |
131 | MP0002006_tumorigenesis | 0.73801838 |
132 | MP0002254_reproductive_system_inflammat | 0.73563018 |
133 | MP0002089_abnormal_postnatal_growth/wei | 0.73474985 |
134 | MP0004134_abnormal_chest_morphology | 0.73456222 |
135 | MP0003136_yellow_coat_color | 0.73445632 |
136 | MP0009840_abnormal_foam_cell | 0.72878597 |
137 | MP0001119_abnormal_female_reproductive | 0.72820824 |
138 | MP0005381_digestive/alimentary_phenotyp | 0.72340385 |
139 | MP0010386_abnormal_urinary_bladder | 0.72246799 |
140 | MP0005174_abnormal_tail_pigmentation | 0.72234733 |
141 | MP0005395_other_phenotype | 0.72111316 |
142 | MP0009278_abnormal_bone_marrow | 0.70824448 |
143 | MP0003183_abnormal_peptide_metabolism | 0.69431426 |
144 | MP0005171_absent_coat_pigmentation | 0.68568342 |
145 | MP0000767_abnormal_smooth_muscle | 0.67399541 |
146 | MP0003866_abnormal_defecation | 0.67321045 |
147 | MP0001188_hyperpigmentation | 0.67044740 |
148 | MP0006292_abnormal_olfactory_placode | 0.64451104 |
149 | MP0000249_abnormal_blood_vessel | 0.64268480 |
150 | MP0003763_abnormal_thymus_physiology | 0.63425841 |
151 | MP0003795_abnormal_bone_structure | 0.62134383 |
152 | MP0002168_other_aberrant_phenotype | 0.61407952 |
153 | MP0005257_abnormal_intraocular_pressure | 0.60425555 |
154 | MP0000579_abnormal_nail_morphology | 0.59545724 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent abscess formation (HP:0002722) | 6.71278815 |
2 | Recurrent bacterial skin infections (HP:0005406) | 5.83223608 |
3 | Eczematoid dermatitis (HP:0000976) | 5.37809921 |
4 | Retrobulbar optic neuritis (HP:0100654) | 5.23228369 |
5 | Optic neuritis (HP:0100653) | 5.23228369 |
6 | Orchitis (HP:0100796) | 5.03602235 |
7 | Myositis (HP:0100614) | 4.65023437 |
8 | Pendular nystagmus (HP:0012043) | 4.41379137 |
9 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.23989625 |
10 | Systemic lupus erythematosus (HP:0002725) | 4.23904949 |
11 | Abnormality of macrophages (HP:0004311) | 4.11220103 |
12 | Chronic obstructive pulmonary disease (HP:0006510) | 4.07646544 |
13 | Obstructive lung disease (HP:0006536) | 4.07646544 |
14 | Stomatitis (HP:0010280) | 3.88745307 |
15 | Congenital sensorineural hearing impairment (HP:0008527) | 3.86858863 |
16 | Prostate neoplasm (HP:0100787) | 3.81132734 |
17 | Gingivitis (HP:0000230) | 3.79296883 |
18 | Recurrent skin infections (HP:0001581) | 3.68274957 |
19 | Mediastinal lymphadenopathy (HP:0100721) | 3.63816634 |
20 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.61345642 |
21 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.46988817 |
22 | Chromsome breakage (HP:0040012) | 3.39225805 |
23 | Abolished electroretinogram (ERG) (HP:0000550) | 3.29044139 |
24 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.25303130 |
25 | Short 1st metacarpal (HP:0010034) | 3.16157709 |
26 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 3.16157709 |
27 | Abnormality of the 1st metacarpal (HP:0010009) | 3.14454734 |
28 | Recurrent fungal infections (HP:0002841) | 3.03640046 |
29 | Confusion (HP:0001289) | 3.00580705 |
30 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.00236218 |
31 | Recurrent cutaneous fungal infections (HP:0011370) | 3.00236218 |
32 | Keratoconjunctivitis sicca (HP:0001097) | 2.99651452 |
33 | Abnormality of proline metabolism (HP:0010907) | 2.99001145 |
34 | Hydroxyprolinuria (HP:0003080) | 2.99001145 |
35 | Pulmonary infiltrates (HP:0002113) | 2.95530359 |
36 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.94610639 |
37 | Abnormality of the nasal septum (HP:0000419) | 2.89786882 |
38 | Pustule (HP:0200039) | 2.86418664 |
39 | Agitation (HP:0000713) | 2.84696336 |
40 | Autoimmune thrombocytopenia (HP:0001973) | 2.82776361 |
41 | Severe visual impairment (HP:0001141) | 2.80319795 |
42 | Keratoconjunctivitis (HP:0001096) | 2.76713474 |
43 | Short phalanx of the thumb (HP:0009660) | 2.76615056 |
44 | Vasculitis (HP:0002633) | 2.75969635 |
45 | Abnormality of glycolipid metabolism (HP:0010969) | 2.75443326 |
46 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.75443326 |
47 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.75443326 |
48 | Abnormal hair whorl (HP:0010721) | 2.67558075 |
49 | Short femoral neck (HP:0100864) | 2.66681545 |
50 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 2.64315445 |
51 | Periodontitis (HP:0000704) | 2.60722207 |
52 | Vacuolated lymphocytes (HP:0001922) | 2.60442343 |
53 | Recurrent pneumonia (HP:0006532) | 2.60202333 |
54 | Abnormality of the prostate (HP:0008775) | 2.58669211 |
55 | Decreased circulating renin level (HP:0003351) | 2.56244860 |
56 | Genetic anticipation (HP:0003743) | 2.54505833 |
57 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.51713459 |
58 | Meningitis (HP:0001287) | 2.50903068 |
59 | Spondylolisthesis (HP:0003302) | 2.49563179 |
60 | Pigmentary retinal degeneration (HP:0001146) | 2.47610449 |
61 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.44409956 |
62 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.42852954 |
63 | Porencephaly (HP:0002132) | 2.38585632 |
64 | Arterial thrombosis (HP:0004420) | 2.35867261 |
65 | Spontaneous hematomas (HP:0007420) | 2.34731847 |
66 | Xerostomia (HP:0000217) | 2.31983218 |
67 | Bone cyst (HP:0012062) | 2.31918636 |
68 | Pancreatic cysts (HP:0001737) | 2.31412854 |
69 | Hematochezia (HP:0002573) | 2.30434694 |
70 | Thick nail (HP:0001805) | 2.30060255 |
71 | Glomerulopathy (HP:0100820) | 2.29082562 |
72 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.28724645 |
73 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.28724645 |
74 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.28724645 |
75 | Hemoptysis (HP:0002105) | 2.28608278 |
76 | True hermaphroditism (HP:0010459) | 2.26931482 |
77 | Keratoconus (HP:0000563) | 2.26199371 |
78 | Increased corneal curvature (HP:0100692) | 2.26199371 |
79 | Leukocytosis (HP:0001974) | 2.23125567 |
80 | Decreased central vision (HP:0007663) | 2.22306632 |
81 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.21642638 |
82 | Malnutrition (HP:0004395) | 2.21429287 |
83 | Pulmonary fibrosis (HP:0002206) | 2.20787216 |
84 | Mucopolysacchariduria (HP:0008155) | 2.19908367 |
85 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.19908367 |
86 | Submucous cleft hard palate (HP:0000176) | 2.16783595 |
87 | Congenital stationary night blindness (HP:0007642) | 2.16631989 |
88 | Cheilitis (HP:0100825) | 2.16048519 |
89 | Pancreatic fibrosis (HP:0100732) | 2.15400116 |
90 | Abnormality of vitamin B metabolism (HP:0004340) | 2.15235130 |
91 | Methylmalonic aciduria (HP:0012120) | 2.13715101 |
92 | Gastrointestinal infarctions (HP:0005244) | 2.13218736 |
93 | Basal ganglia calcification (HP:0002135) | 2.12865382 |
94 | Axonal loss (HP:0003447) | 2.12795543 |
95 | Glomerulonephritis (HP:0000099) | 2.10159847 |
96 | Disinhibition (HP:0000734) | 2.09980110 |
97 | Encephalitis (HP:0002383) | 2.08963297 |
98 | Metabolic alkalosis (HP:0200114) | 2.07719412 |
99 | Abnormality of DNA repair (HP:0003254) | 2.07585941 |
100 | Xanthomatosis (HP:0000991) | 2.07486243 |
101 | Hypergonadotropic hypogonadism (HP:0000815) | 2.04819296 |
102 | Parakeratosis (HP:0001036) | 2.04626183 |
103 | Poor head control (HP:0002421) | 2.04045174 |
104 | Decreased subcutaneous fat (HP:0001002) | 2.03856267 |
105 | Aplasia/hypoplasia of the femur (HP:0005613) | 2.02790557 |
106 | Recurrent lower respiratory tract infections (HP:0002783) | 2.00233664 |
107 | Aplasia/Hypoplasia of the phalanges of the thumb (HP:0009658) | 2.00008426 |
108 | Progressive cerebellar ataxia (HP:0002073) | 1.98033102 |
109 | Loss of speech (HP:0002371) | 1.96829533 |
110 | Metaphyseal irregularity (HP:0003025) | 1.96757160 |
111 | Recurrent viral infections (HP:0004429) | 1.95925612 |
112 | IgG deficiency (HP:0004315) | 1.95876927 |
113 | Cellulitis (HP:0100658) | 1.95328520 |
114 | Anorexia (HP:0002039) | 1.95002950 |
115 | Clumsiness (HP:0002312) | 1.94291562 |
116 | Ventricular fibrillation (HP:0001663) | 1.94270984 |
117 | Clubbing of toes (HP:0100760) | 1.93592901 |
118 | Asplenia (HP:0001746) | 1.93087461 |
119 | Chorioretinal atrophy (HP:0000533) | 1.92545030 |
120 | Peritonitis (HP:0002586) | 1.92064088 |
121 | Hypoplasia of the fovea (HP:0007750) | 1.91746843 |
122 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.91746843 |
123 | Aplasia/Hypoplasia involving the pelvis (HP:0009103) | 1.91555595 |
124 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 1.90765231 |
125 | Inflammation of the large intestine (HP:0002037) | 1.89759779 |
126 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.87959907 |
127 | Gingival bleeding (HP:0000225) | 1.86108439 |
128 | Dysostosis multiplex (HP:0000943) | 1.85851965 |
129 | Abnormality of the costochondral junction (HP:0000919) | 1.85407016 |
130 | 3-Methylglutaconic aciduria (HP:0003535) | 1.84969284 |
131 | Late onset (HP:0003584) | 1.84629888 |
132 | Interstitial pulmonary disease (HP:0006530) | 1.84114531 |
133 | Cystic liver disease (HP:0006706) | 1.83261912 |
134 | Petechiae (HP:0000967) | 1.82990855 |
135 | Abnormality of male internal genitalia (HP:0000022) | 1.82573615 |
136 | Chronic diarrhea (HP:0002028) | 1.82377416 |
137 | Furrowed tongue (HP:0000221) | 1.82060744 |
138 | Urticaria (HP:0001025) | 1.81966496 |
139 | Acute myeloid leukemia (HP:0004808) | 1.81337443 |
140 | Conjunctival hamartoma (HP:0100780) | 1.80796392 |
141 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.80491945 |
142 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.79920235 |
143 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.79516882 |
144 | Abnormality of binocular vision (HP:0011514) | 1.79345346 |
145 | Diplopia (HP:0000651) | 1.79345346 |
146 | Abnormality of vitamin metabolism (HP:0100508) | 1.79163747 |
147 | Alveolar cell carcinoma (HP:0006519) | 1.76006744 |
148 | Complement deficiency (HP:0004431) | 1.75258603 |
149 | Short hallux (HP:0010109) | 1.74343212 |
150 | Abnormality of the pericardium (HP:0001697) | 1.73499664 |
151 | Flat capital femoral epiphysis (HP:0003370) | 1.73299955 |
152 | Abnormality of the endocardium (HP:0004306) | 1.72902069 |
153 | Increased cerebral lipofuscin (HP:0011813) | 1.72009887 |
154 | Methylmalonic acidemia (HP:0002912) | 1.72002224 |
155 | Flared iliac wings (HP:0002869) | 1.70326651 |
156 | Osteomyelitis (HP:0002754) | 1.69228232 |
157 | Myocardial infarction (HP:0001658) | 1.68847095 |
158 | Agnosia (HP:0010524) | 1.68545957 |
159 | Abnormality of B cell number (HP:0010975) | 1.68296472 |
160 | Widely patent fontanelles and sutures (HP:0004492) | 1.67907419 |
161 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.67341955 |
162 | Abnormality of the renal cortex (HP:0011035) | 1.66570242 |
163 | Posterior subcapsular cataract (HP:0007787) | 1.66300489 |
164 | Aseptic necrosis (HP:0010885) | 1.65448744 |
165 | Arthropathy (HP:0003040) | 1.65350168 |
166 | Duplicated collecting system (HP:0000081) | 1.63308973 |
167 | Progressive visual loss (HP:0000529) | 1.63141587 |
168 | Thyroiditis (HP:0100646) | 1.61379099 |
169 | Keratitis (HP:0000491) | 1.59098405 |
170 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.58974872 |
171 | Eosinophilia (HP:0001880) | 1.58918626 |
172 | Premature loss of primary teeth (HP:0006323) | 1.57704157 |
173 | Hepatosplenomegaly (HP:0001433) | 1.57312409 |
174 | Abnormality of the fovea (HP:0000493) | 1.56650916 |
175 | Abnormality of the pleura (HP:0002103) | 1.56034797 |
176 | Adrenal hypoplasia (HP:0000835) | 1.55559782 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BLK | 4.46068472 |
2 | ACVR1B | 4.02700696 |
3 | MAP3K14 | 3.40372181 |
4 | IRAK3 | 3.17579178 |
5 | IRAK4 | 3.10236796 |
6 | WNK4 | 2.47742898 |
7 | TYK2 | 2.32164234 |
8 | MAP4K1 | 2.22294047 |
9 | TAOK3 | 2.16357448 |
10 | TXK | 2.12659779 |
11 | PRKD2 | 2.12455554 |
12 | IKBKB | 2.10496897 |
13 | STK39 | 2.09511955 |
14 | EPHA3 | 1.91420515 |
15 | IKBKE | 1.91338554 |
16 | BMPR1B | 1.89391613 |
17 | KIT | 1.86776690 |
18 | MAP3K13 | 1.82811526 |
19 | TBK1 | 1.82658515 |
20 | RIPK4 | 1.78598488 |
21 | BMPR2 | 1.75641217 |
22 | MUSK | 1.74269251 |
23 | EPHB1 | 1.74058157 |
24 | NEK9 | 1.72206829 |
25 | MAP2K6 | 1.71799200 |
26 | PINK1 | 1.69074080 |
27 | ZAK | 1.66706111 |
28 | CLK1 | 1.65077890 |
29 | BRAF | 1.61687714 |
30 | PIM2 | 1.60893595 |
31 | PLK4 | 1.57787507 |
32 | ERN1 | 1.57419409 |
33 | CSK | 1.53235634 |
34 | MAP3K11 | 1.52031621 |
35 | GRK6 | 1.51524995 |
36 | IRAK1 | 1.44391373 |
37 | JAK3 | 1.44024793 |
38 | CHUK | 1.42913824 |
39 | DDR2 | 1.42583910 |
40 | MST1R | 1.40347705 |
41 | EPHA2 | 1.38201575 |
42 | ERBB4 | 1.37905997 |
43 | MAP3K6 | 1.35914688 |
44 | NUAK1 | 1.35367719 |
45 | SIK3 | 1.33535267 |
46 | DAPK2 | 1.31724254 |
47 | TRPM7 | 1.27530600 |
48 | JAK1 | 1.25267471 |
49 | PBK | 1.24276901 |
50 | TAOK1 | 1.23550181 |
51 | TEC | 1.22040283 |
52 | FGR | 1.19062521 |
53 | STK38L | 1.18098991 |
54 | MAP4K2 | 1.17970155 |
55 | SIK1 | 1.17061760 |
56 | EIF2AK2 | 1.14884334 |
57 | OXSR1 | 1.12579395 |
58 | ABL2 | 1.11268928 |
59 | PRKG2 | 1.06496818 |
60 | PIM1 | 1.05783380 |
61 | ARAF | 1.05204982 |
62 | TNK2 | 1.05128117 |
63 | CDK8 | 1.04246656 |
64 | MAP2K2 | 1.01220838 |
65 | CDC42BPA | 0.99816524 |
66 | LYN | 0.98631604 |
67 | STK3 | 0.98067738 |
68 | PIK3CA | 0.97809581 |
69 | CAMKK2 | 0.96299184 |
70 | HCK | 0.95680132 |
71 | NLK | 0.92327391 |
72 | CSF1R | 0.91977122 |
73 | CASK | 0.90413176 |
74 | IRAK2 | 0.88505381 |
75 | MATK | 0.87214024 |
76 | PRKCI | 0.87116678 |
77 | ERBB2 | 0.86544807 |
78 | FGFR4 | 0.85738892 |
79 | TYRO3 | 0.85557888 |
80 | MAP3K12 | 0.84194166 |
81 | STK10 | 0.83738179 |
82 | FES | 0.83553167 |
83 | PRPF4B | 0.83478778 |
84 | EPHB2 | 0.82615995 |
85 | NEK6 | 0.81807232 |
86 | ADRBK2 | 0.80846301 |
87 | GRK7 | 0.80839530 |
88 | MAPK11 | 0.80669813 |
89 | RPS6KA6 | 0.80410131 |
90 | LMTK2 | 0.79662802 |
91 | SYK | 0.79558038 |
92 | BTK | 0.78286207 |
93 | ZAP70 | 0.77452540 |
94 | FRK | 0.75044238 |
95 | LCK | 0.74793643 |
96 | CDK9 | 0.74129635 |
97 | DYRK2 | 0.73084646 |
98 | YES1 | 0.72562013 |
99 | SIK2 | 0.72402135 |
100 | LATS1 | 0.72104623 |
101 | TGFBR2 | 0.69076120 |
102 | MST4 | 0.68793024 |
103 | MAPKAPK5 | 0.67814363 |
104 | TTK | 0.67670011 |
105 | STK24 | 0.65449779 |
106 | PKN1 | 0.64623727 |
107 | INSRR | 0.64395086 |
108 | ABL1 | 0.63132543 |
109 | NME2 | 0.62489389 |
110 | TNIK | 0.62326127 |
111 | CAMK1D | 0.62226764 |
112 | SGK2 | 0.60923583 |
113 | RPS6KC1 | 0.60144224 |
114 | RPS6KL1 | 0.60144224 |
115 | RPS6KA4 | 0.59546927 |
116 | PTK6 | 0.58457873 |
117 | MAP3K1 | 0.57628473 |
118 | MAPKAPK3 | 0.55857065 |
119 | PRKCZ | 0.55196509 |
120 | JAK2 | 0.54637693 |
121 | TLK1 | 0.54623383 |
122 | MARK3 | 0.54431290 |
123 | PDPK1 | 0.53563795 |
124 | MELK | 0.53557280 |
125 | ITK | 0.53337156 |
126 | RIPK1 | 0.52654678 |
127 | CSNK1A1 | 0.50622654 |
128 | TAOK2 | 0.50307566 |
129 | PDK1 | 0.50251413 |
130 | WNK3 | 0.47604446 |
131 | MOS | 0.46936005 |
132 | CDK3 | 0.46700000 |
133 | PRKCD | 0.46680186 |
134 | SGK223 | 0.46353556 |
135 | SGK494 | 0.46353556 |
136 | RPS6KA5 | 0.44260357 |
137 | HIPK2 | 0.44152932 |
138 | RPS6KA2 | 0.43140181 |
139 | GRK1 | 0.42097848 |
140 | AKT3 | 0.41009456 |
141 | FGFR3 | 0.40378986 |
142 | PRKCG | 0.40215362 |
143 | PRKAA2 | 0.38296055 |
144 | PRKACG | 0.37763900 |
145 | MAPK13 | 0.34993564 |
146 | MKNK2 | 0.33904587 |
147 | MAP3K3 | 0.33858871 |
148 | PRKCQ | 0.33217157 |
149 | PIK3CG | 0.31658595 |
150 | PRKCE | 0.31300407 |
151 | MAPKAPK2 | 0.31073491 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.96360341 |
2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.71222493 |
3 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.67715338 |
4 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.59715516 |
5 | Renin-angiotensin system_Homo sapiens_hsa04614 | 2.59671772 |
6 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.58842385 |
7 | Malaria_Homo sapiens_hsa05144 | 2.51046106 |
8 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.43777413 |
9 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.32437475 |
10 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.30555453 |
11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.29163482 |
12 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.22896425 |
13 | Other glycan degradation_Homo sapiens_hsa00511 | 2.21726991 |
14 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.12180842 |
15 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.03144221 |
16 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.00541890 |
17 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.00297122 |
18 | Legionellosis_Homo sapiens_hsa05134 | 1.96167117 |
19 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.91907075 |
20 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.90790700 |
21 | Tuberculosis_Homo sapiens_hsa05152 | 1.89630203 |
22 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.89415474 |
23 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.78111075 |
24 | Pertussis_Homo sapiens_hsa05133 | 1.77402690 |
25 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.73917013 |
26 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.73089649 |
27 | Allograft rejection_Homo sapiens_hsa05330 | 1.70734276 |
28 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.67258665 |
29 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.66769511 |
30 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.65561411 |
31 | Measles_Homo sapiens_hsa05162 | 1.56099777 |
32 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.53320856 |
33 | Lysosome_Homo sapiens_hsa04142 | 1.52646406 |
34 | Phagosome_Homo sapiens_hsa04145 | 1.51402308 |
35 | Histidine metabolism_Homo sapiens_hsa00340 | 1.51092598 |
36 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.48952788 |
37 | Salmonella infection_Homo sapiens_hsa05132 | 1.47635582 |
38 | Asthma_Homo sapiens_hsa05310 | 1.47462550 |
39 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.41293160 |
40 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.40891574 |
41 | Retinol metabolism_Homo sapiens_hsa00830 | 1.37282295 |
42 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.34254189 |
43 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.33813554 |
44 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.32931954 |
45 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.31660752 |
46 | Influenza A_Homo sapiens_hsa05164 | 1.28584802 |
47 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.27837925 |
48 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.27540679 |
49 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.26478070 |
50 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.25101352 |
51 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.24579221 |
52 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.24239717 |
53 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.23359448 |
54 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.23289089 |
55 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.22515181 |
56 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.21156749 |
57 | Shigellosis_Homo sapiens_hsa05131 | 1.20358422 |
58 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.18584618 |
59 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.14307005 |
60 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.12846547 |
61 | Apoptosis_Homo sapiens_hsa04210 | 1.10202007 |
62 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.10076970 |
63 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.09157421 |
64 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.08989253 |
65 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.08944560 |
66 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.00942155 |
67 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.00067289 |
68 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.99731943 |
69 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.98669097 |
70 | Hepatitis B_Homo sapiens_hsa05161 | 0.98005638 |
71 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.96211763 |
72 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.89976118 |
73 | Homologous recombination_Homo sapiens_hsa03440 | 0.89942338 |
74 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.86385792 |
75 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.86038550 |
76 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.83971433 |
77 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.83579127 |
78 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.83354301 |
79 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.82819935 |
80 | Mineral absorption_Homo sapiens_hsa04978 | 0.82565254 |
81 | Amoebiasis_Homo sapiens_hsa05146 | 0.82422110 |
82 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.81418177 |
83 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.81244851 |
84 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.80096677 |
85 | ABC transporters_Homo sapiens_hsa02010 | 0.79558954 |
86 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.79025409 |
87 | Galactose metabolism_Homo sapiens_hsa00052 | 0.77527028 |
88 | Basal transcription factors_Homo sapiens_hsa03022 | 0.77505806 |
89 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.76862104 |
90 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.75217241 |
91 | Hepatitis C_Homo sapiens_hsa05160 | 0.74295721 |
92 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.74241757 |
93 | Bile secretion_Homo sapiens_hsa04976 | 0.73670409 |
94 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.73576723 |
95 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.72865319 |
96 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.72645301 |
97 | Phototransduction_Homo sapiens_hsa04744 | 0.72259608 |
98 | Sulfur relay system_Homo sapiens_hsa04122 | 0.71059017 |
99 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.70360570 |
100 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.66243665 |
101 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.65249091 |
102 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.63386733 |
103 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.63305177 |
104 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.63147911 |
105 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.63101764 |
106 | Viral myocarditis_Homo sapiens_hsa05416 | 0.62002588 |
107 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.61918204 |
108 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.61513284 |
109 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.60991668 |
110 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.60706347 |
111 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.60630935 |
112 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.58990606 |
113 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.57597358 |
114 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.57389815 |
115 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.56995680 |
116 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.56301288 |
117 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.56107832 |
118 | Insulin resistance_Homo sapiens_hsa04931 | 0.54140567 |
119 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.51275586 |
120 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.50513705 |
121 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.50408558 |
122 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.49923596 |
123 | Peroxisome_Homo sapiens_hsa04146 | 0.46601360 |
124 | Renin secretion_Homo sapiens_hsa04924 | 0.45448876 |
125 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.44114831 |
126 | Insulin secretion_Homo sapiens_hsa04911 | 0.44106425 |
127 | Melanoma_Homo sapiens_hsa05218 | 0.43660643 |
128 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.43475941 |
129 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.42001310 |
130 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.41831482 |
131 | Platelet activation_Homo sapiens_hsa04611 | 0.41437402 |
132 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.40965730 |
133 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.40319488 |
134 | Cell cycle_Homo sapiens_hsa04110 | 0.40270721 |
135 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.39824171 |
136 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.38203883 |
137 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.37454914 |
138 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.37410188 |
139 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.37221128 |
140 | Nicotine addiction_Homo sapiens_hsa05033 | 0.36354045 |
141 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.36294830 |
142 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.35153600 |
143 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.34834398 |
144 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.34443241 |
145 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.33829061 |
146 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.32620629 |
147 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.32451393 |
148 | HTLV-I infection_Homo sapiens_hsa05166 | 0.32372296 |
149 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.30366689 |
150 | Taste transduction_Homo sapiens_hsa04742 | 0.26162704 |